Boule Diagnostics AB (BOUL) - Total Assets

Latest as of June 2025: Skr465.40 Million SEK ≈ $50.08 Million USD

Based on the latest financial reports, Boule Diagnostics AB (BOUL) holds total assets worth Skr465.40 Million SEK (≈ $50.08 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Boule Diagnostics AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Boule Diagnostics AB - Total Assets Trend (2005–2024)

This chart illustrates how Boule Diagnostics AB's total assets have evolved over time, based on quarterly financial data. Explore Boule Diagnostics AB long-term investment allocation to see how much of total assets are deployed in long-term investments.

Boule Diagnostics AB - Asset Composition Analysis

Current Asset Composition (December 2024)

Boule Diagnostics AB's total assets of Skr465.40 Million consist of 43.2% current assets and 56.8% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr22.65 Million	3.9%
Accounts Receivable	Skr167.40 Million	28.4%
Inventory	Skr59.10 Million	10.0%
Property, Plant & Equipment	Skr39.48 Million	6.7%
Intangible Assets	Skr99.70 Million	16.9%
Goodwill	Skr91.92 Million	15.6%

Asset Composition Trend (2005–2024)

This chart illustrates how Boule Diagnostics AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Boule Diagnostics AB worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Boule Diagnostics AB's current assets represent 43.2% of total assets in 2024, an increase from 0.0% in 2005.
Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 14.0% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, a decrease from 94.0% in 2005.
Asset Diversification: The largest asset category is accounts receivable at 28.4% of total assets.

Boule Diagnostics AB Competitors by Total Assets

Key competitors of Boule Diagnostics AB based on total assets are shown below.

Company	Country	Total Assets
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$90.55 Million
Medacta Group SA SW:MOVE	Switzerland	CHF860.76 Million
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.52 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
Xiangyu Medical Co. Ltd. A SHG:688626	China	CN¥3.27 Billion
INKON Life Technology Co Ltd SHE:300143	China	CN¥4.17 Billion

Boule Diagnostics AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.02	1.23	1.42
Quick Ratio	0.74	0.93	1.09
Cash Ratio	0.10	0.00	0.00
Working Capital	Skr5.40 Million	Skr53.30 Million	Skr69.90 Million

Boule Diagnostics AB - Advanced Valuation Insights

This section examines the relationship between Boule Diagnostics AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.36
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	-21.8%
Total Assets	Skr590.20 Million
Market Capitalization	$13.37 Million USD

Valuation Analysis

Below Book Valuation: The market values Boule Diagnostics AB's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Boule Diagnostics AB's assets decreased by 21.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Boule Diagnostics AB (2005–2024)

The table below shows the annual total assets of Boule Diagnostics AB from 2005 to 2024.

Year	Total Assets	Change
2024-12-31	Skr590.20 Million ≈ $63.51 Million	-21.84%
2023-12-31	Skr755.11 Million ≈ $81.26 Million	-0.64%
2022-12-31	Skr759.96 Million ≈ $81.78 Million	+32.85%
2021-12-31	Skr572.03 Million ≈ $61.56 Million	+19.24%
2020-12-31	Skr479.71 Million ≈ $51.62 Million	-18.26%
2019-12-31	Skr586.87 Million ≈ $63.16 Million	+17.17%
2018-12-31	Skr500.85 Million ≈ $53.90 Million	+20.25%
2017-12-31	Skr416.49 Million ≈ $44.82 Million	+14.32%
2016-12-31	Skr364.33 Million ≈ $39.21 Million	+15.48%
2015-12-31	Skr315.48 Million ≈ $33.95 Million	+12.69%
2014-12-31	Skr279.95 Million ≈ $30.13 Million	+26.84%
2013-12-31	Skr220.72 Million ≈ $23.75 Million	-19.81%
2012-12-31	Skr275.23 Million ≈ $29.62 Million	+1.24%
2011-12-31	Skr271.85 Million ≈ $29.26 Million	+31.89%
2010-12-31	Skr206.11 Million ≈ $22.18 Million	+37.99%
2009-12-31	Skr149.37 Million ≈ $16.07 Million	-11.28%
2008-12-31	Skr168.36 Million ≈ $18.12 Million	-1.90%
2007-12-31	Skr171.62 Million ≈ $18.47 Million	+3.75%
2006-12-31	Skr165.42 Million ≈ $17.80 Million	-5.28%
2005-12-31	Skr174.63 Million ≈ $18.79 Million	--

About Boule Diagnostics AB

ST:BOUL Sweden Medical Devices

Market Cap

$13.37 Million

Skr124.27 Million SEK

Market Cap Rank

#26319 Global

#560 in Sweden

Share Price

Skr3.20

Change (1 day)

-3.03%

52-Week Range

Skr3.15 - Skr10.30

All Time High

Skr74.05